Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Cabot

Showing results (21-30 of 178) with videos related to

Pageof 18
Sort By:
Anti-Cancer Agents in Medicinal Chemistry|June 29, 2011
Sphingolipid metabolism and drug resistance in hematological malignanciesValerie Gouaze-Andersson, Myles C Cabot
The Journal of Biological Chemistry|October 15, 1990
Vasopressin-induced polyphosphoinositide and phosphatidylcholine degradation in fibroblasts. Temporal relationship for formation of phospholipase C and phospholipase D hydrolysis productsC F Huang, M C Cabot
Methods in Molecular Biology (Clifton, N.J.)|October 24, 2003
Development of a mammalian Tet-on expression cell line: glucosylceramide synthase regulates TNF-alpha-induced apoptosisYong-Yu Liu, Myles C Cabot
Cancer Research|January 1, 1987
Modification of serum, pancreatic, and microbial lipase activities by phorbol diestersZ C Zhang, M C Cabot
The Journal of Emergency Medicine|December 17, 2014
Persistent effects after camphor ingestion: a case report and literature reviewCynthia D Santos, Jennifer C Cabot
Biochimica Et Biophysica Acta|October 3, 2006
Glycosphingolipids and drug resistanceValerie Gouaze-Andersson, Myles C Cabot
The Journal of Medical Research|December 9, 2009
Iodophilia: A Preliminary ReportE A Locke, R C Cabot
Cancer Chemotherapy and Pharmacology|November 13, 2010
Cytotoxic responses to N-(4-hydroxyphenyl)retinamide in human pancreatic cancer cellsMaria C Messner, Myles C Cabot
Advances in Experimental Medicine and Biology|October 6, 2010
Glucosylceramide in humansMaria C Messner, Myles C Cabot
Cancer Letters|October 1, 1983
Acetate utilization and fatty acid metabolism in phorbol ester and dimethyl sulfoxide-differentiated human leukemia cellsR J Lackey, M C Cabot
Pageof 18

Showing results (21-30 of 178) with videos related to

Sort By:
Pageof 18
Anti-Cancer Agents in Medicinal Chemistry|June 29, 2011
Sphingolipid metabolism and drug resistance in hematological malignanciesValerie Gouaze-Andersson, Myles C Cabot
The Journal of Biological Chemistry|October 15, 1990
Vasopressin-induced polyphosphoinositide and phosphatidylcholine degradation in fibroblasts. Temporal relationship for formation of phospholipase C and phospholipase D hydrolysis productsC F Huang, M C Cabot
Methods in Molecular Biology (Clifton, N.J.)|October 24, 2003
Development of a mammalian Tet-on expression cell line: glucosylceramide synthase regulates TNF-alpha-induced apoptosisYong-Yu Liu, Myles C Cabot
Cancer Research|January 1, 1987
Modification of serum, pancreatic, and microbial lipase activities by phorbol diestersZ C Zhang, M C Cabot
The Journal of Emergency Medicine|December 17, 2014
Persistent effects after camphor ingestion: a case report and literature reviewCynthia D Santos, Jennifer C Cabot
Biochimica Et Biophysica Acta|October 3, 2006
Glycosphingolipids and drug resistanceValerie Gouaze-Andersson, Myles C Cabot
The Journal of Medical Research|December 9, 2009
Iodophilia: A Preliminary ReportE A Locke, R C Cabot
Cancer Chemotherapy and Pharmacology|November 13, 2010
Cytotoxic responses to N-(4-hydroxyphenyl)retinamide in human pancreatic cancer cellsMaria C Messner, Myles C Cabot
Advances in Experimental Medicine and Biology|October 6, 2010
Glucosylceramide in humansMaria C Messner, Myles C Cabot
Cancer Letters|October 1, 1983
Acetate utilization and fatty acid metabolism in phorbol ester and dimethyl sulfoxide-differentiated human leukemia cellsR J Lackey, M C Cabot
Pageof 18